Niche focus Leverage ePD's specialized expertise in model-informed drug development for oncology and other therapeutic areas to position as a high-value partner for biotech startups and mid-size companies seeking efficient dose selection and decision-making in early to mid-stage programs.

Strategic collaboration Target venture-backed and growth-stage companies that need pharmacometrics and quantitative systems pharmacology support across drug development, offering scalable engagement models from advisory to full project execution.

Competitive edge Differentiate from larger CROs by highlighting fast turnaround, decision-oriented outputs, and intimate collaboration with clients, suitable for companies with lean teams seeking specialized modeling to de-risk development timelines.

Growth channels Capitalize on a lean organization footprint to pursue outbound BD efforts toward emerging biotechs and virtual-focused firms, plus build case studies demonstrating impact on dose selection, program timelines, and Go/No-Go decisions.

Tech-enabled delivery Promote the use of advanced pharmacometrics methods and QSP techniques as a core value proposition, while showcasing a modern tech stack and secure collaboration tools to reassure potential partners about data integrity and project efficiency.